BOK Financial’s AbbVie ABBV Stock Holding History

BOK Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-90	Closed	-$324K	–	1069
2023 Q1	$324K	Buy	+90	New	+$13.8K	0.01%	616

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BOK Financial's ABBV Position: Q2 2026 in Review

BOK Financial reduced its AbbVie (ABBV) stake by 3.1% in Q2 2026, selling an estimated $1.35M and leaving 194,942 shares worth $49.1M. The position accounts for 0.68% of the portfolio, ranked #31.

BOK Financial first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $123M in Q1 2021. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

BOK Financial held 194,942 shares of AbbVie worth $49.1M as of Q2 2026.
BOK Financial sold 6,298 AbbVie shares in Q2 2026, an estimated $1.35M.
AbbVie made up 0.68% of BOK Financial's portfolio in Q2 2026, its #31 holding.
BOK Financial first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
BOK Financial's AbbVie position peaked at $123M in Q1 2021.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.